Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Gynäkologie in der Praxis
Erschienen in:

01.11.2017 | Die Mädchensprechstunde

Die Genetik der In(Sub)fertilität

verfasst von: Dr. Allessandra Tramontana

Erschienen in: Gynäkologie in der Praxis | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Auszug

Von Prim. Univ.-Doz. Dr. Hans-Christoph Duba, Vorstand des Instituts für medizinische Genetik, Facharzt für medizinische Genetik (Humangenetik), Kepler Universitätsklinikum, Linz …
Vorheriger Artikel Positionspapier der Nordamerikanischen Menopause Gesellschaft (NAMS) zur HRT
Nächster Artikel Die Wechseljahre ganz natürlich
Literatur
1.
Clementini E, Palka C, Iezzi I, Stuppia L, Guanciali-Franchi P, Tiboni GM (2005) Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum Reprod 20(2):437–442CrossRefPubMed
2.
Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R et al (2013) Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril 99(5):1324–1331.e1CrossRefPubMedPubMedCentral
3.
Wolff DJ, Van Dyke DL, Powell CM (2010) Laboratory guideline for Turner syndrome. Genet Med 12(1):52–55CrossRefPubMed
4.
5.
Mathur A, Stekol L, Schatz D, MacLaren NK, Scott ML, Lippe B (1991) The parental origin of the single X chromosome in Turner syndrome: lack of correlation with parental age or clinical phenotype. Am J Hum Genet 48(4):682–686PubMedPubMedCentral
6.
Romero ST, Geiersbach KB, Paxton CN, Rose NC, Schisterman EF, Branch DW et al (2015) Differentiation of genetic abnormalities in early pregnancy loss. Ultrasound Obstet Gynecol 45(1):89–94CrossRefPubMed
7.
Azmanov DN, Milachich TV, Zaharieva BM, Michailova GI, Dimitrova VG, Karagiozova ZH et al (2007) Profile of chromosomal aberrations in different gestational age spontaneous abortions detected by comparative genomic hybridization. Eur J Obstet Gynecol Reprod Biol 131(2):127–131CrossRefPubMed
8.
Ferguson-Smith MA (1965) Karyotype-phenotype correlations in gonadal dysgenesis and their bearing on the pathogenesis of malformations. J Med Genet 2(2):142–155CrossRefPubMedPubMedCentral
9.
Simpson JL (1975) Gonadal dysgenesis and abnormalities of the human sex chromosomes: current status of phenotypic-karyotypic correlations. Birth Defects Orig Artic Ser 11(4):23–59PubMed
10.
Lunding SA, Aksglaede L, Anderson RA, Main KM, Juul A, Hagen CP et al (2015) AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 turner syndrome patients. J Clin Endocrinol Metab 100(7):E1030–E1038CrossRefPubMed
11.
Hadnott TN, Gould HN, Gharib AM, Bondy CA (2011) Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril 95(7):2251–2256CrossRefPubMedPubMedCentral
12.
Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G (1997) Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab 82(6):1810–1813PubMed
13.
Gravholt CH, Fedder J, Naeraa RW, Muller J (2000) Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 85(9):3199–3202PubMed
14.
Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA (2008) Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol 9(3):239–246CrossRefPubMed
15.
Otter M, Schrander-Stumpel CT, Curfs LM (2010) Triple X syndrome: a review of the literature. Eur J Hum Genet 18(3):265–271CrossRefPubMed
16.
Barr ML, Sergovich FR, Carr DH, Saver EL (1969) The triplo-X female: an appraisal based on a study of 12 cases and a review of the literature. Can Med Assoc J 101(5):247–258PubMedPubMedCentral
17.
18.
Therrell BL (2001) Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30(1):15–30CrossRefPubMed
19.
Therrell BL Jr., Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L et al (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101(4 Pt 1):583–590CrossRefPubMed
20.
Ferenczi A, Garami M, Kiss E, Pek M, Sasvari-Szekely M, Barta C et al (1999) Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 84(7):2369–2372PubMed
21.
Lee HH, Kuo JM, Chao HT, Lee YJ, Chang JG, Tsai CH et al (2000) Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J Clin Endocrinol Metab 85(2):597–600PubMed
22.
Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldhausl W, Vierhapper H (2005) Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population. J Clin Endocrinol Metab 90(2):775–778CrossRefPubMed
23.
24.
Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT et al (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90(2):584–595CrossRefPubMedPubMedCentral
25.
Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A et al (2004) Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. J Clin Endocrinol Metab 89(5):2228–2236CrossRefPubMed
26.
Mulaikal RM, Migeon CJ, Rock JA (1987) Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 316(4):178–182CrossRefPubMed
27.
Nordenskjold A, Holmdahl G, Frisen L, Falhammar H, Filipsson H, Thoren M et al (2008) Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 93(2):380–386CrossRefPubMed
28.
New MI (2006) Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91(11):4205–4214CrossRefPubMed
29.
Birnbaum MD, Rose LI (1979) The partial adrenocortical hydroxylase deficiency syndrome in infertile women. Fertil Steril 32(5):536–541CrossRefPubMed
30.
Moran C, Azziz R, Weintrob N, Witchel SF, Rohmer V, Dewailly D et al (2006) Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 91(9):3451–3456CrossRefPubMed
31.
Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG (1996) Estimates of human fertility and pregnancy loss. Fertil Steril 65(3):503–509CrossRefPubMed
Metadaten
Titel
Die Genetik der In(Sub)fertilität
verfasst von
Dr. Allessandra Tramontana
Publikationsdatum
01.11.2017
Verlag
Springer Vienna
Erschienen in
Gynäkologie in der Praxis / Ausgabe 4/2017
Print ISSN: 3005-0758
Elektronische ISSN: 3005-0766
DOI
https://doi.org/10.1007/s41974-017-0015-7

Weitere Artikel der Ausgabe 4/2017

Mitteilungen der Österreichischen IVF-Gesellschaft

  • Mitteilungen der Österreichischen IVF-Gesellschaft

Präeklampsie

  • Originalien

Correction: Hypogonadismus bei jungen Frauen

  • Correction

News-Screen Assistierte Reproduktion

  • News-Screen Assistierte Reproduktion

Alkoholkonsum und Menopause

  • News-Screen Menopause

Bildgebende Methoden in der Mammadiagnostik – welche ist die beste?

  • Originalien